SICK at a glance
IFRS figures for the SICK Group
| 2019 | 2020 | 2021 | 2022 | 2023 | |
Net sales (in millions of euros) | 1,750.7 | 1,700.2 | 1,964 | 2.189,8 | 2.307,3 |
| EBIT (in millions of euros) | 132.9 | 140.6 | 202.3 | 164,6 | 189,4 |
| Annual yield (in millions of euros) | 93.9 | 101.1 | 147.8 | 119,5 | 134,4 |
| Cash flow (in millions of euros) | 212.7 | 227.7 | 231.1 | 55,0 | 117,6 |
| Employees as of December 31 | 10,204 | 10,433 | 11,022 | 11.909 | 12.185 |
| R&D expenditure (in millions of euros) | 202.0 | 201.1 | 210.3 | 240,8 | 269,8 |
| Earnings per share (in EUR) | 3.58 | 3.86 | 5.64 | 4,56 | 5,12 |